Rebecca Baines
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rebecca Baines has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Arunangsu Chatterjee
Centre for Health Technology University of Plymouth Plymouth United Kingdom
9 shared publications - Hannah Bradwell
Centre for Health Technology, University of Plymouth, Plymouth, United Kingdom
7 shared publications - Ray Brian Jones
Centre for Health Technology, University of Plymouth, Plymouth, UK
7 shared publications - Sebastian Stevens
Centre for Health Technology, University of Plymouth, Plymouth, United Kingdom
6 shared publications - John Tredinnick-Rowe
Peninsula Dental Social Enterprise, Plymouth, UK
4 shared publications - Katie Jane Edwards
Centre for Health Technology University of Plymouth Plymouth United Kingdom
4 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 5 March 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e50421
Patient and Public Willingness to Share Personal Health Data for Third-Party or Secondary Uses: Systematic Review
Background: International advances in information communication, eHealth, and other digital health technologies have led to significant expansions in the collection and analysis of personal health data. However, following a series of high-profile data sharing scandals and the emergence of COVID-19, critical exploration of public willingness to share personal health data remains limited, particularly for third-party or secondary uses. Objective: This systematic review aims to explore factors that affect public willingness to share personal health data for third-party or secondary uses. Methods: A systematic search of 6 databases (MEDLINE, Embase, PsycINFO, CINAHL, Scopus, and SocINDEX) was conducted with review findings analyzed using inductive-thematic analysis and synthesized using a narrative approach. Results: Of the 13,949 papers identified, 135 were included. Factors most commonly identified as a barrier to data sharing from a public perspective included data privacy, security, and management concerns. Other factors found to influence willingness to share personal health data included the type of data being collected (ie, perceived sensitivity); the type of user requesting their data to be shared, including their perceived motivation, profit prioritization, and ability to directly impact patient care; trust in the data user, as well as in associated processes, often established through individual choice and control over what data are shared with whom, when, and for how long, supported by appropriate models of dynamic consent; the presence of a feedback loop; and clearly articulated benefits or issue relevance including valued incentivization and compensation at both an individual and collective or societal level. Conclusions: There is general, yet conditional public support for sharing personal health data for third-party or secondary use. Clarity, transparency, and individual control over who has access to what data, when, and for how long are widely regarded as essential prerequisites for public data sharing support. Individual levels of control and choice need to operate within the auspices of assured data privacy and security processes, underpinned by dynamic and responsive models of consent that prioritize individual or collective benefits over and above commercial gain. Failure to understand, design, and refine data sharing approaches in response to changeable patient preferences will only jeopardize the tangible benefits of data sharing practices being fully realized.
- 5 March 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e50421
Top Cited PapersOpen AccessPatient and Public Willingness to Share Personal Health Data for Third-Party or Secondary Uses: Systematic Review
Background: International advances in information communication, eHealth, and other digital health technologies have led to significant expansions in the collection and analysis of personal health data. However, following a series of high-profile data sharing scandals and the emergence of COVID-19, critical exploration of public willingness to share personal health data remains limited, particularly for third-party or secondary uses. Objective: This systematic review aims to explore factors that affect public willingness to share personal health data for third-party or secondary uses. Methods: A systematic search of 6 databases (MEDLINE, Embase, PsycINFO, CINAHL, Scopus, and SocINDEX) was conducted with review findings analyzed using inductive-thematic analysis and synthesized using a narrative approach. Results: Of the 13,949 papers identified, 135 were included. Factors most commonly identified as a barrier to data sharing from a public perspective included data privacy, security, and management concerns. Other factors found to influence willingness to share personal health data included the type of data being collected (ie, perceived sensitivity); the type of user requesting their data to be shared, including their perceived motivation, profit prioritization, and ability to directly impact patient care; trust in the data user, as well as in associated processes, often established through individual choice and control over what data are shared with whom, when, and for how long, supported by appropriate models of dynamic consent; the presence of a feedback loop; and clearly articulated benefits or issue relevance including valued incentivization and compensation at both an individual and collective or societal level. Conclusions: There is general, yet conditional public support for sharing personal health data for third-party or secondary use. Clarity, transparency, and individual control over who has access to what data, when, and for how long are widely regarded as essential prerequisites for public data sharing support. Individual levels of control and choice need to operate within the auspices of assured data privacy and security processes, underpinned by dynamic and responsive models of consent that prioritize individual or collective benefits over and above commercial gain. Failure to understand, design, and refine data sharing approaches in response to changeable patient preferences will only jeopardize the tangible benefits of data sharing practices being fully realized.
- Open Access
- 22 November 2023
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 11 (1) , e46937
Association Between the Characteristics of mHealth Apps and User Input During Development and Testing: Secondary Analysis of App Assessment Data
Background: User involvement is increasingly acknowledged as a central part of health care innovation. However, meaningful user involvement during the development and testing of mobile health apps is often not fully realized. Objective: This study aims to examine in which areas user input is most prevalent and whether there is an association between user inclusion and compliance with best practices for mobile health apps. Methods: A secondary analysis was conducted on an assessment data set of 1595 health apps. The data set contained information on whether the apps had been developed or tested with user input and whether they followed best practices across several domains. Background information was also available regarding the apps’ country of origin, targeted condition areas, subjective user ratings, download numbers, and risk (as per the National Institute for Health and Care Excellence Evidence Standards Framework [ESF]). Descriptive statistics, Mann-Whitney U tests, and Pearson chi-square analyses were applied to the data. Results: User involvement was reported by 8.71% (139/1595) of apps for only the development phase, by 33.67% (537/1595) of apps for only the testing phase, by 21.88% (349/1595) of apps for both phases, and by 35.74% (570/1595) of apps for neither phase. The highest percentage of health apps with reported user input during development was observed in Denmark (19/24, 79%); in the condition areas of diabetes (38/79, 48%), cardiology (15/32, 47%), pain management (20/43, 47%), and oncology (25/54, 46%); and for high app risk (ESF tier 3a; 105/263, 39.9%). The highest percentage of health apps with reported user input during testing was observed in Belgium (10/11, 91%), Sweden (29/34, 85%), and France (13/16, 81%); in the condition areas of neurodiversity (42/52, 81%), respiratory health (58/76, 76%), cardiology (23/32, 72%), and diabetes (56/79, 71%); and for high app risk (ESF tier 3a; 176/263, 66.9%). Notably, apps that reported seeking user input during testing demonstrated significantly more downloads than those that did not (P=.008), and user inclusion was associated with better compliance with best practices in clinical assurance, data privacy, risk management, and user experience. Conclusions: The countries and condition areas in which the highest percentage of health apps with user involvement were observed tended to be those with higher digital maturity in health care and more funding availability, respectively. This suggests that there may be a trade-off between developers’ willingness or ability to involve users and the need to meet challenges arising from infrastructure limitations and financial constraints. Moreover, the finding of a positive association between user inclusion and compliance with best practices indicates that, where no other guidance is available, users may benefit from prioritizing health apps developed with user input as the latter may be a proxy for broader app quality.
- 22 November 2023
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 11 (1) , e46937
Open AccessAssociation Between the Characteristics of mHealth Apps and User Input During Development and Testing: Secondary Analysis of App Assessment Data
Background: User involvement is increasingly acknowledged as a central part of health care innovation. However, meaningful user involvement during the development and testing of mobile health apps is often not fully realized. Objective: This study aims to examine in which areas user input is most prevalent and whether there is an association between user inclusion and compliance with best practices for mobile health apps. Methods: A secondary analysis was conducted on an assessment data set of 1595 health apps. The data set contained information on whether the apps had been developed or tested with user input and whether they followed best practices across several domains. Background information was also available regarding the apps’ country of origin, targeted condition areas, subjective user ratings, download numbers, and risk (as per the National Institute for Health and Care Excellence Evidence Standards Framework [ESF]). Descriptive statistics, Mann-Whitney U tests, and Pearson chi-square analyses were applied to the data. Results: User involvement was reported by 8.71% (139/1595) of apps for only the development phase, by 33.67% (537/1595) of apps for only the testing phase, by 21.88% (349/1595) of apps for both phases, and by 35.74% (570/1595) of apps for neither phase. The highest percentage of health apps with reported user input during development was observed in Denmark (19/24, 79%); in the condition areas of diabetes (38/79, 48%), cardiology (15/32, 47%), pain management (20/43, 47%), and oncology (25/54, 46%); and for high app risk (ESF tier 3a; 105/263, 39.9%). The highest percentage of health apps with reported user input during testing was observed in Belgium (10/11, 91%), Sweden (29/34, 85%), and France (13/16, 81%); in the condition areas of neurodiversity (42/52, 81%), respiratory health (58/76, 76%), cardiology (23/32, 72%), and diabetes (56/79, 71%); and for high app risk (ESF tier 3a; 176/263, 66.9%). Notably, apps that reported seeking user input during testing demonstrated significantly more downloads than those that did not (P=.008), and user inclusion was associated with better compliance with best practices in clinical assurance, data privacy, risk management, and user experience. Conclusions: The countries and condition areas in which the highest percentage of health apps with user involvement were observed tended to be those with higher digital maturity in health care and more funding availability, respectively. This suggests that there may be a trade-off between developers’ willingness or ability to involve users and the need to meet challenges arising from infrastructure limitations and financial constraints. Moreover, the finding of a positive association between user inclusion and compliance with best practices indicates that, where no other guidance is available, users may benefit from prioritizing health apps developed with user input as the latter may be a proxy for broader app quality.
- Open Access
- 30 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Patient and Public Willingness to Share Personal Health Data for Third-Party or Secondary Uses: Systematic Review (Preprint)
BACKGROUND International advances in information communication, eHealth, and other digital health technologies have led to significant expansions in the collection and analysis of personal health data. However, following a series of high-profile data sharing scandals and the emergence of COVID-19, critical exploration of public willingness to share personal health data remains limited, particularly for third-party or secondary uses. OBJECTIVE This systematic review aims to explore factors that affect public willingness to share personal health data for third-party or secondary uses. METHODS A systematic search of 6 databases (MEDLINE, Embase, PsycINFO, CINAHL, Scopus, and SocINDEX) was conducted with review findings analyzed using inductive-thematic analysis and synthesized using a narrative approach. RESULTS Of the 13,949 papers identified, 135 were included. Factors most commonly identified as a barrier to data sharing from a public perspective included data privacy, security, and management concerns. Other factors found to influence willingness to share personal health data included the type of data being collected (ie, perceived sensitivity); the type of user requesting their data to be shared, including their perceived motivation, profit prioritization, and ability to directly impact patient care; trust in the data user, as well as in associated processes, often established through individual choice and control over what data are shared with whom, when, and for how long, supported by appropriate models of dynamic consent; the presence of a feedback loop; and clearly articulated benefits or issue relevance including valued incentivization and compensation at both an individual and collective or societal level. CONCLUSIONS There is general, yet conditional public support for sharing personal health data for third-party or secondary use. Clarity, transparency, and individual control over who has access to what data, when, and for how long are widely regarded as essential prerequisites for public data sharing support. Individual levels of control and choice need to operate within the auspices of assured data privacy and security processes, underpinned by dynamic and responsive models of consent that prioritize individual or collective benefits over and above commercial gain. Failure to understand, design, and refine data sharing approaches in response to changeable patient preferences will only jeopardize the tangible benefits of data sharing practices being fully realized.
- 30 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPatient and Public Willingness to Share Personal Health Data for Third-Party or Secondary Uses: Systematic Review (Preprint)
BACKGROUND International advances in information communication, eHealth, and other digital health technologies have led to significant expansions in the collection and analysis of personal health data. However, following a series of high-profile data sharing scandals and the emergence of COVID-19, critical exploration of public willingness to share personal health data remains limited, particularly for third-party or secondary uses. OBJECTIVE This systematic review aims to explore factors that affect public willingness to share personal health data for third-party or secondary uses. METHODS A systematic search of 6 databases (MEDLINE, Embase, PsycINFO, CINAHL, Scopus, and SocINDEX) was conducted with review findings analyzed using inductive-thematic analysis and synthesized using a narrative approach. RESULTS Of the 13,949 papers identified, 135 were included. Factors most commonly identified as a barrier to data sharing from a public perspective included data privacy, security, and management concerns. Other factors found to influence willingness to share personal health data included the type of data being collected (ie, perceived sensitivity); the type of user requesting their data to be shared, including their perceived motivation, profit prioritization, and ability to directly impact patient care; trust in the data user, as well as in associated processes, often established through individual choice and control over what data are shared with whom, when, and for how long, supported by appropriate models of dynamic consent; the presence of a feedback loop; and clearly articulated benefits or issue relevance including valued incentivization and compensation at both an individual and collective or societal level. CONCLUSIONS There is general, yet conditional public support for sharing personal health data for third-party or secondary use. Clarity, transparency, and individual control over who has access to what data, when, and for how long are widely regarded as essential prerequisites for public data sharing support. Individual levels of control and choice need to operate within the auspices of assured data privacy and security processes, underpinned by dynamic and responsive models of consent that prioritize individual or collective benefits over and above commercial gain. Failure to understand, design, and refine data sharing approaches in response to changeable patient preferences will only jeopardize the tangible benefits of data sharing practices being fully realized.
- Open Access
- 2 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
The EnACT framework: Achieving meaningful patient and public involvement in digital innovation, implementation and evaluation using a modified Delphi methodology (Preprint)
BACKGROUND Defined as a public priority, digital health is considered essential for creating sustainable and equitable health care systems on an international scale. OBJECTIVE However, while widely acknowledged as beneficial, recent research shows that patients and the public are rarely involved in the design, implementation, and evaluation of digital health technologies. Furthermore, stakeholder consensus on the principles that underpin meaningful involvement in digital health specifically is not yet readily available. METHODS This research draws on a four-phase methodology: i) extensive systematic review of peer-reviewed literature; ii) inductive thematic analysis of review findings; iii) co-design workshop to identify best practice principles; and iv) consensus testing of identified principles amongst key stakeholders using a modified Delphi methodology. This manuscript reports on phases three and four only. The systematic review methodology and findings are reported elsewhere. RESULTS Thirteen principles categorised into four headings (i) engage, ii) acknowledge, reward and value, iii) communicate and iv) trust and transparency) termed the EnACT framework were co-designed by workshop participants. Nine principles achieved ‘essential’ consensus (>75% agreement) status by 14 expert respondents. Principles with the highest level of consensus included: providing clear assurances and information about patient confidentiality, data privacy and security (100%) and creating a space where people feel safe and supported in sharing their digital innovation ideas and suggestions (100%). Providing clear assurances and information about patient confidentiality, data privacy and security was repeatedly described as essential and totally non-negotiable by participants. Principles that failed to achieve consensus included: co-designing engaging activities and evaluation methods (50% essential vs 50% desirable); building in sufficient time and resources (57% vs 43%); developing a feedback loop (71% vs 29%) and advertising the potential benefits of being involved (43% vs 57%). One prevailing justification for categorising principles as desirable was a perceived disparity between ‘preferable’ or ‘desirable’ best practise, and the ‘realities’ of implementing such principles. With the exception of one principle categorised as irrelevant by one innovator, no other principles were considered irrelevant. No alternative principles were suggested by expert respondents. CONCLUSIONS This research advances existing knowledge and understanding by providing previously unavailable consensus on the principles that underpin meaningful Patient Public Involvement in digital health innovation, implementation and evaluation. Expert respondents suggest such principles should be aspired to wherever possible to ensure involvement optimisation. However, stakeholders need to be sufficiently supported and operating within adequately resourced and receptive environments if high quality involvement is to become a reality. Failure to do so may mean patient and public involvement in digital health continues to remain a rarely practised, or tokenistic exercise that jeopardises innovation relevance, value, and utility, ultimately endangering the desired vision of digital health creating sustainable and equitable health care systems on an international scale.
- 2 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe EnACT framework: Achieving meaningful patient and public involvement in digital innovation, implementation and evaluation using a modified Delphi methodology (Preprint)
BACKGROUND Defined as a public priority, digital health is considered essential for creating sustainable and equitable health care systems on an international scale. OBJECTIVE However, while widely acknowledged as beneficial, recent research shows that patients and the public are rarely involved in the design, implementation, and evaluation of digital health technologies. Furthermore, stakeholder consensus on the principles that underpin meaningful involvement in digital health specifically is not yet readily available. METHODS This research draws on a four-phase methodology: i) extensive systematic review of peer-reviewed literature; ii) inductive thematic analysis of review findings; iii) co-design workshop to identify best practice principles; and iv) consensus testing of identified principles amongst key stakeholders using a modified Delphi methodology. This manuscript reports on phases three and four only. The systematic review methodology and findings are reported elsewhere. RESULTS Thirteen principles categorised into four headings (i) engage, ii) acknowledge, reward and value, iii) communicate and iv) trust and transparency) termed the EnACT framework were co-designed by workshop participants. Nine principles achieved ‘essential’ consensus (>75% agreement) status by 14 expert respondents. Principles with the highest level of consensus included: providing clear assurances and information about patient confidentiality, data privacy and security (100%) and creating a space where people feel safe and supported in sharing their digital innovation ideas and suggestions (100%). Providing clear assurances and information about patient confidentiality, data privacy and security was repeatedly described as essential and totally non-negotiable by participants. Principles that failed to achieve consensus included: co-designing engaging activities and evaluation methods (50% essential vs 50% desirable); building in sufficient time and resources (57% vs 43%); developing a feedback loop (71% vs 29%) and advertising the potential benefits of being involved (43% vs 57%). One prevailing justification for categorising principles as desirable was a perceived disparity between ‘preferable’ or ‘desirable’ best practise, and the ‘realities’ of implementing such principles. With the exception of one principle categorised as irrelevant by one innovator, no other principles were considered irrelevant. No alternative principles were suggested by expert respondents. CONCLUSIONS This research advances existing knowledge and understanding by providing previously unavailable consensus on the principles that underpin meaningful Patient Public Involvement in digital health innovation, implementation and evaluation. Expert respondents suggest such principles should be aspired to wherever possible to ensure involvement optimisation. However, stakeholders need to be sufficiently supported and operating within adequately resourced and receptive environments if high quality involvement is to become a reality. Failure to do so may mean patient and public involvement in digital health continues to remain a rarely practised, or tokenistic exercise that jeopardises innovation relevance, value, and utility, ultimately endangering the desired vision of digital health creating sustainable and equitable health care systems on an international scale.
- Open Access
- 12 April 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 108, 24-32
Analysing patient-generated data to understand behaviours and characteristics of women with epilepsy of childbearing years: A prospective cohort study
- 12 April 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 108, 24-32
Open AccessAnalysing patient-generated data to understand behaviours and characteristics of women with epilepsy of childbearing years: A prospective cohort study
- Open Access
- 3 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Association Between the Characteristics of mHealth Apps and User Input During Development and Testing: Secondary Analysis of App Assessment Data (Preprint)
BACKGROUND User involvement is increasingly acknowledged as a central part of health care innovation. However, meaningful user involvement during the development and testing of mobile health apps is often not fully realized. OBJECTIVE This study aims to examine in which areas user input is most prevalent and whether there is an association between user inclusion and compliance with best practices for mobile health apps. METHODS A secondary analysis was conducted on an assessment data set of 1595 health apps. The data set contained information on whether the apps had been developed or tested with user input and whether they followed best practices across several domains. Background information was also available regarding the apps’ country of origin, targeted condition areas, subjective user ratings, download numbers, and risk (as per the National Institute for Health and Care Excellence Evidence Standards Framework [ESF]). Descriptive statistics, Mann-Whitney U tests, and Pearson chi-square analyses were applied to the data. RESULTS User involvement was reported by 8.71% (139/1595) of apps for only the development phase, by 33.67% (537/1595) of apps for only the testing phase, by 21.88% (349/1595) of apps for both phases, and by 35.74% (570/1595) of apps for neither phase. The highest percentage of health apps with reported user input during development was observed in Denmark (19/24, 79%); in the condition areas of diabetes (38/79, 48%), cardiology (15/32, 47%), pain management (20/43, 47%), and oncology (25/54, 46%); and for high app risk (ESF tier 3a; 105/263, 39.9%). The highest percentage of health apps with reported user input during testing was observed in Belgium (10/11, 91%), Sweden (29/34, 85%), and France (13/16, 81%); in the condition areas of neurodiversity (42/52, 81%), respiratory health (58/76, 76%), cardiology (23/32, 72%), and diabetes (56/79, 71%); and for high app risk (ESF tier 3a; 176/263, 66.9%). Notably, apps that reported seeking user input during testing demonstrated significantly more downloads than those that did not (P=.008), and user inclusion was associated with better compliance with best practices in clinical assurance, data privacy, risk management, and user experience. CONCLUSIONS The countries and condition areas in which the highest percentage of health apps with user involvement were observed tended to be those with higher digital maturity in health care and more funding availability, respectively. This suggests that there may be a trade-off between developers’ willingness or ability to involve users and the need to meet challenges arising from infrastructure limitations and financial constraints. Moreover, the finding of a positive association between user inclusion and compliance with best practices indicates that, where no other guidance is available, users may benefit from prioritizing health apps developed with user input as the latter may be a proxy for broader app quality.
- 3 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAssociation Between the Characteristics of mHealth Apps and User Input During Development and Testing: Secondary Analysis of App Assessment Data (Preprint)
BACKGROUND User involvement is increasingly acknowledged as a central part of health care innovation. However, meaningful user involvement during the development and testing of mobile health apps is often not fully realized. OBJECTIVE This study aims to examine in which areas user input is most prevalent and whether there is an association between user inclusion and compliance with best practices for mobile health apps. METHODS A secondary analysis was conducted on an assessment data set of 1595 health apps. The data set contained information on whether the apps had been developed or tested with user input and whether they followed best practices across several domains. Background information was also available regarding the apps’ country of origin, targeted condition areas, subjective user ratings, download numbers, and risk (as per the National Institute for Health and Care Excellence Evidence Standards Framework [ESF]). Descriptive statistics, Mann-Whitney U tests, and Pearson chi-square analyses were applied to the data. RESULTS User involvement was reported by 8.71% (139/1595) of apps for only the development phase, by 33.67% (537/1595) of apps for only the testing phase, by 21.88% (349/1595) of apps for both phases, and by 35.74% (570/1595) of apps for neither phase. The highest percentage of health apps with reported user input during development was observed in Denmark (19/24, 79%); in the condition areas of diabetes (38/79, 48%), cardiology (15/32, 47%), pain management (20/43, 47%), and oncology (25/54, 46%); and for high app risk (ESF tier 3a; 105/263, 39.9%). The highest percentage of health apps with reported user input during testing was observed in Belgium (10/11, 91%), Sweden (29/34, 85%), and France (13/16, 81%); in the condition areas of neurodiversity (42/52, 81%), respiratory health (58/76, 76%), cardiology (23/32, 72%), and diabetes (56/79, 71%); and for high app risk (ESF tier 3a; 176/263, 66.9%). Notably, apps that reported seeking user input during testing demonstrated significantly more downloads than those that did not (P=.008), and user inclusion was associated with better compliance with best practices in clinical assurance, data privacy, risk management, and user experience. CONCLUSIONS The countries and condition areas in which the highest percentage of health apps with user involvement were observed tended to be those with higher digital maturity in health care and more funding availability, respectively. This suggests that there may be a trade-off between developers’ willingness or ability to involve users and the need to meet challenges arising from infrastructure limitations and financial constraints. Moreover, the finding of a positive association between user inclusion and compliance with best practices indicates that, where no other guidance is available, users may benefit from prioritizing health apps developed with user input as the latter may be a proxy for broader app quality.
- Open Access
- 8 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Acceptability and usability of a mobile app for family obesity prevention and management: A mixed-methods study (Preprint)
BACKGROUND Childhood obesity is a growing global public health concern. Digital tools could encourage behaviour change for healthy lifestyles, but a better understanding of their strategies, adoption, and impact is needed to ensure that available tools actually benefit users. Health Education England developed a digital app (‘NoObesity’) to facilitate and improve communication between families and healthcare providers and to support healthy lifestyle behaviour change. OBJECTIVE The aim of the study was to collect evidence about the adoption and implementation of a family-focused app for childhood obesity prevention to inform further development. Specific objectives included examining the app’s usability, acceptability, and perceived impact, identifying barriers to engaging with the app and to changing behaviour, and gathering suggestions for improvement. METHODS 225 parents were enrolled to evaluate a family app for childhood obesity prevention. Users’ experiences with the app and its perceived impact on motivation, self-efficacy, and behaviours were analysed based on two conceptual frameworks: the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) and Non-adoption, Abandonment and Challenges to the Scale-up, Spread and Suitability (NASSS) frameworks. The study took place between March 2020 and April 2021. RESULTS Thematic analysis found that goal-setting, prompts, and suggestions helped support parents’ awareness, motivation, and self-efficacy. Motivation and accessibility were key barriers to behaviour, and engagement was limited by a lack of novel content. Key suggestions included more content and improved notifications and progress tracking. Usability scores were ‘average’ (M = 70·3/100, 95% CI: 63·8-76·8). CONCLUSIONS Family-focused mobile health apps have potential as acceptable tools to help support healthy behaviour change and the prevention and management of childhood obesity. Feedback from healthcare professionals could improve families’ motivation and self-efficacy but digital tools will need to integrate into existing routines to enable clinical adoption. CLINICALTRIAL ClinicalTrials.gov (NCT05261555)
- 8 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAcceptability and usability of a mobile app for family obesity prevention and management: A mixed-methods study (Preprint)
BACKGROUND Childhood obesity is a growing global public health concern. Digital tools could encourage behaviour change for healthy lifestyles, but a better understanding of their strategies, adoption, and impact is needed to ensure that available tools actually benefit users. Health Education England developed a digital app (‘NoObesity’) to facilitate and improve communication between families and healthcare providers and to support healthy lifestyle behaviour change. OBJECTIVE The aim of the study was to collect evidence about the adoption and implementation of a family-focused app for childhood obesity prevention to inform further development. Specific objectives included examining the app’s usability, acceptability, and perceived impact, identifying barriers to engaging with the app and to changing behaviour, and gathering suggestions for improvement. METHODS 225 parents were enrolled to evaluate a family app for childhood obesity prevention. Users’ experiences with the app and its perceived impact on motivation, self-efficacy, and behaviours were analysed based on two conceptual frameworks: the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) and Non-adoption, Abandonment and Challenges to the Scale-up, Spread and Suitability (NASSS) frameworks. The study took place between March 2020 and April 2021. RESULTS Thematic analysis found that goal-setting, prompts, and suggestions helped support parents’ awareness, motivation, and self-efficacy. Motivation and accessibility were key barriers to behaviour, and engagement was limited by a lack of novel content. Key suggestions included more content and improved notifications and progress tracking. Usability scores were ‘average’ (M = 70·3/100, 95% CI: 63·8-76·8). CONCLUSIONS Family-focused mobile health apps have potential as acceptable tools to help support healthy behaviour change and the prevention and management of childhood obesity. Feedback from healthcare professionals could improve families’ motivation and self-efficacy but digital tools will need to integrate into existing routines to enable clinical adoption. CLINICALTRIAL ClinicalTrials.gov (NCT05261555)
- Top Cited PapersOpen Access
- 8 May 2022
- Published by Wiley in Health Expectations
- Vol. 25 (4) , 1232-1245
Meaningful patient and public involvement in digital health innovation, implementation and evaluation: A systematic review
Introduction: The importance of meaningfully involving patients and the public in digital health innovation is widely acknowledged, but often poorly understood. This review, therefore, sought to explore how patients and the public are involved in digital health innovation and to identify factors that support and inhibit meaningful patient and public involvement (PPI) in digital health innovation, implementation and evaluation.Methods: Searches were undertaken from 2010 to July 2020 in the electronic databases MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus and ACM Digital Library. Grey literature searches were also undertaken using the Patient Experience Library database and Google Scholar.Results: Of the 10,540 articles identified, 433 were included. The majority of included articles were published in the United States, United Kingdom, Canada and Australia, with representation from 42 countries highlighting the international relevance of PPI in digital health. 112 topic areas where PPI had reportedly taken place were identified. Areas most often described included cancer (n = 50), mental health (n = 43), diabetes (n = 26) and long‐term conditions (n = 19). Interestingly, over 133 terms were used to describe PPI; few were explicitly defined. Patients were often most involved in the final, passive stages of an innovation journey, for example, usability testing, where the ability to proactively influence change was severely limited. Common barriers to achieving meaningful PPI included data privacy and security concerns, not involving patients early enough and lack of trust. Suggested enablers were often designed to counteract such challenges.Conclusions: PPI is largely viewed as valuable and essential in digital health innovation, but rarely practised. Several barriers exist for both innovators and patients, which currently limits the quality, frequency and duration of PPI in digital health innovation, although improvements have been made in the past decade. Some reported barriers and enablers such as the importance of data privacy and security appear to be unique to PPI in digital innovation. Greater efforts should be made to support innovators and patients to become meaningfully involved in digital health innovations from the outset, given its reported benefits and impacts. Stakeholder consensus on the principles that underpin meaningful PPI in digital health innovation would be helpful in providing evidence‐based guidance on how to achieve this.Patient or Public Contribution: This review has received extensive patient and public contributions with a representative from the Patient Experience Library involved throughout the review's conception, from design (including suggested revisions to the search strategy) through to article production and dissemination. Other areas of patient and public contributor involvement include contributing to the inductive thematic analysis process, refining the thematic framework and finalizing theme wording, helping to ensure relevance, value and meaning from a patient perspective. Findings from this review have also been presented to a variety of stakeholders including patients, patient advocates and clinicians through a series of focus groups and webinars. Given their extensive involvement, the representative from the Patient Experience Library is rightly included as an author of this review.
- 8 May 2022
- Published by Wiley in Health Expectations
- Vol. 25 (4) , 1232-1245
Top Cited PapersOpen AccessMeaningful patient and public involvement in digital health innovation, implementation and evaluation: A systematic review
Introduction: The importance of meaningfully involving patients and the public in digital health innovation is widely acknowledged, but often poorly understood. This review, therefore, sought to explore how patients and the public are involved in digital health innovation and to identify factors that support and inhibit meaningful patient and public involvement (PPI) in digital health innovation, implementation and evaluation.Methods: Searches were undertaken from 2010 to July 2020 in the electronic databases MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus and ACM Digital Library. Grey literature searches were also undertaken using the Patient Experience Library database and Google Scholar.Results: Of the 10,540 articles identified, 433 were included. The majority of included articles were published in the United States, United Kingdom, Canada and Australia, with representation from 42 countries highlighting the international relevance of PPI in digital health. 112 topic areas where PPI had reportedly taken place were identified. Areas most often described included cancer (n = 50), mental health (n = 43), diabetes (n = 26) and long‐term conditions (n = 19). Interestingly, over 133 terms were used to describe PPI; few were explicitly defined. Patients were often most involved in the final, passive stages of an innovation journey, for example, usability testing, where the ability to proactively influence change was severely limited. Common barriers to achieving meaningful PPI included data privacy and security concerns, not involving patients early enough and lack of trust. Suggested enablers were often designed to counteract such challenges.Conclusions: PPI is largely viewed as valuable and essential in digital health innovation, but rarely practised. Several barriers exist for both innovators and patients, which currently limits the quality, frequency and duration of PPI in digital health innovation, although improvements have been made in the past decade. Some reported barriers and enablers such as the importance of data privacy and security appear to be unique to PPI in digital innovation. Greater efforts should be made to support innovators and patients to become meaningfully involved in digital health innovations from the outset, given its reported benefits and impacts. Stakeholder consensus on the principles that underpin meaningful PPI in digital health innovation would be helpful in providing evidence‐based guidance on how to achieve this.Patient or Public Contribution: This review has received extensive patient and public contributions with a representative from the Patient Experience Library involved throughout the review's conception, from design (including suggested revisions to the search strategy) through to article production and dissemination. Other areas of patient and public contributor involvement include contributing to the inductive thematic analysis process, refining the thematic framework and finalizing theme wording, helping to ensure relevance, value and meaning from a patient perspective. Findings from this review have also been presented to a variety of stakeholders including patients, patient advocates and clinicians through a series of focus groups and webinars. Given their extensive involvement, the representative from the Patient Experience Library is rightly included as an author of this review.
- Open Access
- 21 March 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (3) , e30486
Exploring Patient and Staff Experiences With Video Consultations During COVID-19 in an English Outpatient Care Setting: Secondary Data Analysis of Routinely Collected Feedback Data
Background: Video consultations (VCs) were rapidly implemented in response to COVID-19 despite modest progress before. Objective: We aim to explore staff and patient experiences with VCs implemented during COVID-19 and use feedback insights to support quality improvement and service development. Methods: Secondary data analysis was conducted on 955 patient and 521 staff responses (from 4234 consultations; 955/4234, 22.6% and 521/4234, 12.3%, respectively) routinely collected following a VC between June and July 2020 in a rural, older adult, and outpatient care setting at a National Health Service Trust. Responses were summarized using descriptive statistics and inductive thematic analysis and presented to Trust stakeholders. Results: Most patients (890/955, 93.2%) reported having good (210/955, 22%) or very good (680/955, 71.2%) experience with VCs and felt listened to and understood (904/955, 94.7%). Most patients accessed their VC alone (806/955, 84.4%) except for those aged ≥71 years (23/58, 40%), with ease of joining VCs negatively associated with age (P<.001). Despite more difficulties joining, older adults were most likely to be satisfied with the technology (46/58, 79%). Patients and staff generally felt that patients’ needs had been met (860/955, 90.1% and 453/521, 86.9%, respectively), although staff appeared to overestimate patient dissatisfaction with VC outcomes (P=.02). Patients (848/955, 88.8%) and staff (419/521, 80.5%) felt able to communicate everything they wanted, although patients were significantly more positive than staff (P<.001). Patient satisfaction with communication was positively associated with technical performance satisfaction (P<.001). Most staff members (466/521, 89.4%) reported positive (185/521, 35.5%) or very positive (281/521, 53.9%) experiences with joining and managing VCs. Staff reported reductions in carbon footprint (380/521, 72.9%) and time (373/521, 71.6%). Most patients (880/955, 92.1%) would choose VCs again. We identified three themes in responses: barriers, including technological difficulties, patient information, and suitability concerns; potential benefits, including reduced stress, enhanced accessibility, cost, and time savings; and suggested improvements, including trial calls, turning music off, photo uploads, expanding written character limit, supporting other internet browsers, and shared online screens. This routine feedback, including evidence to suggest that patients were more satisfied than clinicians had anticipated, was presented to relevant Trust stakeholders, allowing for improved processes and supporting the development of a business case to inform the Trust decision on continuing VCs beyond COVID-19 restrictions. Conclusions: The findings highlight the importance of regularly reviewing and responding to routine feedback following digital service implementation. The feedback helped the Trust improve the VC service, challenge clinician-held assumptions about patient experience, and inform future use of VCs. It has focused improvement efforts on patient information; technological improvements such as blurred backgrounds and interactive whiteboards; and responding to the needs of patients with dementia, communication or cognitive impairment, or lack of appropriate technology. These findings have implications for other health care providers.
- 21 March 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (3) , e30486
Open AccessExploring Patient and Staff Experiences With Video Consultations During COVID-19 in an English Outpatient Care Setting: Secondary Data Analysis of Routinely Collected Feedback Data
Background: Video consultations (VCs) were rapidly implemented in response to COVID-19 despite modest progress before. Objective: We aim to explore staff and patient experiences with VCs implemented during COVID-19 and use feedback insights to support quality improvement and service development. Methods: Secondary data analysis was conducted on 955 patient and 521 staff responses (from 4234 consultations; 955/4234, 22.6% and 521/4234, 12.3%, respectively) routinely collected following a VC between June and July 2020 in a rural, older adult, and outpatient care setting at a National Health Service Trust. Responses were summarized using descriptive statistics and inductive thematic analysis and presented to Trust stakeholders. Results: Most patients (890/955, 93.2%) reported having good (210/955, 22%) or very good (680/955, 71.2%) experience with VCs and felt listened to and understood (904/955, 94.7%). Most patients accessed their VC alone (806/955, 84.4%) except for those aged ≥71 years (23/58, 40%), with ease of joining VCs negatively associated with age (P<.001). Despite more difficulties joining, older adults were most likely to be satisfied with the technology (46/58, 79%). Patients and staff generally felt that patients’ needs had been met (860/955, 90.1% and 453/521, 86.9%, respectively), although staff appeared to overestimate patient dissatisfaction with VC outcomes (P=.02). Patients (848/955, 88.8%) and staff (419/521, 80.5%) felt able to communicate everything they wanted, although patients were significantly more positive than staff (P<.001). Patient satisfaction with communication was positively associated with technical performance satisfaction (P<.001). Most staff members (466/521, 89.4%) reported positive (185/521, 35.5%) or very positive (281/521, 53.9%) experiences with joining and managing VCs. Staff reported reductions in carbon footprint (380/521, 72.9%) and time (373/521, 71.6%). Most patients (880/955, 92.1%) would choose VCs again. We identified three themes in responses: barriers, including technological difficulties, patient information, and suitability concerns; potential benefits, including reduced stress, enhanced accessibility, cost, and time savings; and suggested improvements, including trial calls, turning music off, photo uploads, expanding written character limit, supporting other internet browsers, and shared online screens. This routine feedback, including evidence to suggest that patients were more satisfied than clinicians had anticipated, was presented to relevant Trust stakeholders, allowing for improved processes and supporting the development of a business case to inform the Trust decision on continuing VCs beyond COVID-19 restrictions. Conclusions: The findings highlight the importance of regularly reviewing and responding to routine feedback following digital service implementation. The feedback helped the Trust improve the VC service, challenge clinician-held assumptions about patient experience, and inform future use of VCs. It has focused improvement efforts on patient information; technological improvements such as blurred backgrounds and interactive whiteboards; and responding to the needs of patients with dementia, communication or cognitive impairment, or lack of appropriate technology. These findings have implications for other health care providers.
- Open Access
Use and usability of GP online services: a mixed-methods sequential study, before and during the COVID-19 pandemic, based on qualitative interviews, analysis of routine eConsult usage and feedback data, and assessment of GP websites in Devon and Cornwall, England
Objectives We explored use and usability of general practitioner (GP) online services. Setting Devon and Cornwall, England. Design Mixed-methods sequential study based on qualitative interviews, analysis of routine eConsult usage and feedback data, and assessment of GP websites. Methods First, we interviewed 32 staff and 18 patients from seven practices in June 2018. Second, we used routinely collected consultation meta-data and, third, patient feedback data for all practices using eConsult from June 2018 to March 2021. Lastly, we examined GP websites’ usability in January 2020 and September 2021. Results Interviews suggested practices infrequently involved patients in eConsult implementation. Some patients ‘gamed’ the system to achieve what they wanted. Usage data showed a major increase in eConsult resulting from COVID-19. Women used eConsult twice as much as men. Older had similar eConsult consultation rates to younger patients. Patient feedback forms were completed for fewer than 3% of consultations. Patients were mostly satisfied with eConsult but some had concerns about its length and repetitiveness, lack of continuity over time and between eConsult and medical records. We did not find clear evidence that patients’ suggested improvements were acted on. Finally, few GP websites met accessibility guidelines and may hinder access to online national services such as eConsult. Conclusion Given that, face to face, older people consult more, usage data suggest that older people have reduced online access. That the female-to-male ratio of eConsult use use was even greater than ‘traditional’ face-to-face ratio was unexpected and needs further research. Although eConsult collects and uses routine patient feedback to improve the system, more open systems for patient feedback, such as Care Opinion, may be more effective in helping online systems evolve. Lastly, we question the need for GP websites and suggest that national or regional services are better placed to maintain accessible services.
Open AccessUse and usability of GP online services: a mixed-methods sequential study, before and during the COVID-19 pandemic, based on qualitative interviews, analysis of routine eConsult usage and feedback data, and assessment of GP websites in Devon and Cornwall, England
Objectives We explored use and usability of general practitioner (GP) online services. Setting Devon and Cornwall, England. Design Mixed-methods sequential study based on qualitative interviews, analysis of routine eConsult usage and feedback data, and assessment of GP websites. Methods First, we interviewed 32 staff and 18 patients from seven practices in June 2018. Second, we used routinely collected consultation meta-data and, third, patient feedback data for all practices using eConsult from June 2018 to March 2021. Lastly, we examined GP websites’ usability in January 2020 and September 2021. Results Interviews suggested practices infrequently involved patients in eConsult implementation. Some patients ‘gamed’ the system to achieve what they wanted. Usage data showed a major increase in eConsult resulting from COVID-19. Women used eConsult twice as much as men. Older had similar eConsult consultation rates to younger patients. Patient feedback forms were completed for fewer than 3% of consultations. Patients were mostly satisfied with eConsult but some had concerns about its length and repetitiveness, lack of continuity over time and between eConsult and medical records. We did not find clear evidence that patients’ suggested improvements were acted on. Finally, few GP websites met accessibility guidelines and may hinder access to online national services such as eConsult. Conclusion Given that, face to face, older people consult more, usage data suggest that older people have reduced online access. That the female-to-male ratio of eConsult use use was even greater than ‘traditional’ face-to-face ratio was unexpected and needs further research. Although eConsult collects and uses routine patient feedback to improve the system, more open systems for patient feedback, such as Care Opinion, may be more effective in helping online systems evolve. Lastly, we question the need for GP websites and suggest that national or regional services are better placed to maintain accessible services.